MSSPT PEPTIDE PEN IMMUNE BOOST – R 1200

Thymosin Alpha–1 (Ta1) is a synthetic 28-amino-acid peptide identical to the naturally occurring N-terminal fragment of prothymosin alpha, a protein produced primarily in the thymus gland. Chemical Structure: Ac-Ser–Asp-Ala-Ala-Val-Asp-Thr–Ser–Ser–Glu–Ile-Thr-Thr–Lys–Asp–Leu–Lys-Glu-Lys–Lys-Glu-Val–Val-Glu-Glu-Ala-Glu- Asn-OH 

(Acetylated at N-terminus; free carboxylic acid at C–terminus) 

Mechanism of Action 

Thymosin Alpha–1 acts as a master regulator of immune homeostasis. It binds to toll–like receptors (TLR2/TLR9) on immune cells and activates multiple intracellular signalling pathways (NF-κB, MAPK, STAT, PI3K/Akt). Key effects include: 

• Enhancement of T-cell maturation, differentiation, and activation 
• Stimulation of natural killer (NK) cell cytotoxicity and cytokine production 
• Promotion of dendritic cell maturation and antigen presentation 
• Upregulation of IL-2, IL-10, IFN-y, and IL-12 production 
• Restoration of Th1/Th2 balance and reversal of immunosuppression 
• Direct antiviral, antibacterial, and antifungal activity 
• Increased expression of MHC class I molecules and antioxidant enzymes 

These actions result in broad-spectrum immune potentiation, improved host defence, and accelerated recovery from immune suppression or dysregulation. 

Indications & Usage 

Immune Boost (Thymosin Alpha-1) is used to support and restore immune function. It is indicated for: 

• • Enhancement of immune competence during periods of increased demand (stress, recovery, environmental exposure) 
  • Assistance in age-related or acquired decline in T-cell and NK-cell function 
  • Support for recovery from acute or chronic immune challenges 
  • General immune modulation and resilience at the cellular level 

    Contraindications & Warnings 

    Do not use if you have: 

    • Known hypersensitivity to Thymosin Alpha-1 or any excipient 
    • Active autoimmune disease in acute flare (e.g., uncontrolled rheumatoid arthritis, lupus) 
    • Organ or hematopoietic stem cell transplant recipients on high-dose immunosuppression Active untreated malignancy (unless under oncologist supervision) 
    • Age under 18 years 
    • Pregnancy or breastfeeding

      Warnings 

      • Use only under medical supervision. 
      • Not a substitute for vaccination, antimicrobial therapy, or standard treatment of infections/immunodeficiency. 
      • Monitor for signs of immune overstimulation (fever, rash, arthralgia) during initial use.
      • Discontinue immediately and seek medical attention if severe allergic reactions, organ inflammation, or unexpected symptoms occur. 

        Dosage & Administration 

        • Subcutaneous injection only. 
        • Beginner/Mild Support (0.125 mg): 6 clicks daily- 5 days on / 2 days off (yields ~20 doses) 
        • Moderate Support (0.25 mg): 12 clicks daily- 5 days on /2 days off (yields ~10 doses) 
        • Advanced/Clinical Support (0.5 mg): 24 clicks daily- 5 days on / 2 days off (yields ≈5 doses) Frequency: 5 days on / 2 days off (e.g., Monday-Friday on, Saturday-Sunday off) 

          Administration Instructions

          1. Wash hands and prepare a clean surface. 
          2. Attach a sterile needle. 
          3. Dial the required number of clicks. 
          4. Clean injection site (abdomen or upper thigh) with alcohol swab. 
          5. Insert needle at 45-90° angle and inject slowly. 
          6. Withdraw needle, dispose safely, and cap the pen. 
          7. Rotate injection sites to minimize irritation. 
          8. Always inspect solution before use: Do not inject if cloudy, discoloured, or containing particles. 

             Side Effects 

             Thymosin Alpha-1 is generally very well tolerated with a long safety record. Reported reactions are rare and mild, including: 

             • Transient injection-site redness, itching, or mild swelling 
             • Mild flu-like symptoms (low-grade fever, fatigue, myalgia) during initial doses 
             • Headache or light-headedness 
             • Rare transient changes in appetite or sleep pattern 
             • If any severe or persistent symptoms occur (e.g., high fever, rash, joint swelling, or allergic signs), discontinue use and contact your healthcare provider immediately. 
        • Timing: Every morning 

          Storage & Handling 

          • Store either in refrigerator (fridge); never freeze or in a cool dry place (≤25-30°C / 77-86°F). 
          • Keep pen capped and protected from light and heat. 
          • After first use: Same storage conditions. 
          • Keep out of reach of children. 
          • Discard if expired or solution appears abnormal. 

            Powered by Precision MSSPT 

            Peptide Pen formulations set the standard for research peptide delivery in challenging environments. Powered by exclusive MSSPT, each pen combines buffers, antioxidants, and proprietary agents in a compact, user-friendly injector delivering strict control over pH, light, oxygen, oxidative factors, and moisture even under South Africa’s subtropical variability or the UAE’s extreme desert heat and humidity. This proprietary technology positions Peptide Pen as the premier choice for researchers in these regions: no mixing, no guesswork, and reliable, high-fidelity results despite demanding protocols and climates. Every Peptide Pen is built for exceptional durability, reliability, and performance, providing precision molecular stabilization in every dose, wherever your research takes you. 

            • IMPORTANT NOTICE 

              This product is not intended to diagnose, treat, cure, or prevent any disease. Statements have not been evaluated by the FDA, SAHPRA, or other authorities. Always consult a licensed healthcare provider before use, especially if pregnant, breastfeeding, under 18, or managing medical conditions.